O36.013
Maternal care for anti-D [Rh] antibodies, third trimester
Clinical Classification Guidelines
Medical Intelligence & Overview
Maternal care for anti-D [Rh] antibodies during the third trimester involves specific monitoring and management to prevent potential complications for both mother and baby. Anti-D [Rh] antibodies can develop in pregnant women who are Rh-negative if they are exposed to Rh-positive blood cells, often during pregnancy or childbirth. Proper care during this period aims to minimize risks related to Rh incompatibility, ensuring a healthier pregnancy outcome.
Causes & Symptoms
Clinical Causes: Rh-negative mother being exposed to Rh-positive fetal blood cells. Previous pregnancies with Rh-positive babies. Blood transfusions with Rh-positive blood. Pregnancy complications that cause blood mixing, such as placental abruption or trauma.
Key Symptoms: No noticeable symptoms for the mother. Signs of hemolytic disease in the fetus or newborn, such as jaundice or anemia, which are typically identified through prenatal testing. Maternal symptoms might be related to complications from managing Rh incompatibility, though rarely noticeable before intervention.
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves blood tests to determine the mother's Rh status and detect anti-D antibodies. During pregnancy, fetuses are monitored through ultrasound and fetal blood sampling techniques to assess for anemia. The presence and titers of anti-D antibodies help determine the level of risk and guide management decisions.
Treatment Protocols: Administration of Rh immunoglobulin (RhIg), commonly known as RhoGAM, around the 28th week of pregnancy and within 72 hours after delivery if the baby is Rh-positive. Regular fetal surveillance, including ultrasound assessments for signs of anemia or hydrops fetalis. In cases where fetal anemia is detected, intrauterine blood transfusions may be performed. Postnatal management of the newborn, which includes monitoring for jaundice and hemolytic anemia, and treatments like phototherapy or exchange transfusions if necessary.
Clinical Advice & FAQs
Billing Guidance
Is O36.013 a billable ICD-10 code?
Yes, O36.013 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report O36.013?
Clinical documentation must specify the nature of Maternal care for anti-D [Rh] antibodies, third trimester and any associated comorbidities for accurate reporting.
Cite this Clinical Reference